1. Home
  2. CPK vs RYTM Comparison

CPK vs RYTM Comparison

Compare CPK & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPK
  • RYTM
  • Stock Information
  • Founded
  • CPK 1990
  • RYTM 2008
  • Country
  • CPK United States
  • RYTM United States
  • Employees
  • CPK N/A
  • RYTM N/A
  • Industry
  • CPK Oil & Gas Production
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPK Utilities
  • RYTM Health Care
  • Exchange
  • CPK Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • CPK 2.7B
  • RYTM 3.1B
  • IPO Year
  • CPK N/A
  • RYTM 2017
  • Fundamental
  • Price
  • CPK $124.08
  • RYTM $54.54
  • Analyst Decision
  • CPK Hold
  • RYTM Strong Buy
  • Analyst Count
  • CPK 4
  • RYTM 10
  • Target Price
  • CPK $123.00
  • RYTM $66.90
  • AVG Volume (30 Days)
  • CPK 86.3K
  • RYTM 580.8K
  • Earning Date
  • CPK 02-19-2025
  • RYTM 02-20-2025
  • Dividend Yield
  • CPK 2.07%
  • RYTM N/A
  • EPS Growth
  • CPK N/A
  • RYTM N/A
  • EPS
  • CPK 4.91
  • RYTM N/A
  • Revenue
  • CPK $757,489,000.00
  • RYTM $112,530,000.00
  • Revenue This Year
  • CPK $22.71
  • RYTM $63.77
  • Revenue Next Year
  • CPK $6.95
  • RYTM $44.91
  • P/E Ratio
  • CPK $25.23
  • RYTM N/A
  • Revenue Growth
  • CPK 12.63
  • RYTM 81.55
  • 52 Week Low
  • CPK $98.25
  • RYTM $35.17
  • 52 Week High
  • CPK $134.20
  • RYTM $68.58
  • Technical
  • Relative Strength Index (RSI)
  • CPK 56.28
  • RYTM 43.02
  • Support Level
  • CPK $115.12
  • RYTM $52.71
  • Resistance Level
  • CPK $122.39
  • RYTM $60.12
  • Average True Range (ATR)
  • CPK 2.27
  • RYTM 2.13
  • MACD
  • CPK 0.64
  • RYTM -0.36
  • Stochastic Oscillator
  • CPK 95.42
  • RYTM 23.48

About CPK Chesapeake Utilities Corporation

Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by their respective PSC. Eastern Shore, its natural gas transmission subsidiary, is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.

Share on Social Networks: